生物種
|
リソース名
|
RRC ID
|
タイトル
|
ジャーナル
|
公開日
|
外部リンク
|
ヒト・動物細胞
|
KP4(RCB1005)
|
77543
|
LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models.
|
Invest New Drugs |
2013-8-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Hep G2
|
62747
|
Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells.
|
PLoS One |
2016-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
HuCCT1(RCB1960)
|
52089
|
Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability.
|
J Vasc Interv Radiol |
2015-12-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Hep G2
,
HuH-7
|
44378
|
Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro.
|
Anticancer Res |
2013-4-1 |
Pubmed
|
ヒト・動物細胞
|
GSU(RCB2278)
,
Kato III(RCB2088)
,
KE-97(RCB1435)
,
MKN45(RCB1001)
,
NUGC-4(RCB1939)
|
44366
|
A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities.
|
Mol Cancer Ther |
2013-6-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
HuH-7
|
38122
|
Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma.
|
Cancer Res |
2015-8-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Li-7(RCB1941)
|
36980
|
Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib.
|
BMC Cancer |
2015-4-11 |
Pubmed
Full text
|